期刊文献+

再生障碍性贫血“瘀证”与铁过载的相关性探讨 被引量:1

Overview of Traditional Chinese Medicine on Iron Overload and “Stasis” Syndrome in Aplastic Anemia
下载PDF
导出
摘要 铁过载和中医“血瘀证”在再生障碍性贫血(简称再障)的发生发展中发挥着重要作用。围绕再障“瘀证”的发生机制和临床特征,结合中医“取象比类”和相关临床基础研究进展,系统阐述了铁过载与再障中医“瘀证”潜在的相关性。铁螯合治疗契合“祛瘀生新”的中医理论,有利于改善造血,而从中医“补肾活血”着手,同样有助于疾病临床疗效的提升。 Iron overload and “Stasis syndrome” played a crucial role in the development of aplastic anemia(AA).According to the mechanism and characteristic of “Stasis”,using comparative state and clinical research datum,we elaborated the role of iron overload in the formation of “Stasis” syndrome in AA.Iron chelation can promote the hematopoiesis which goes accordance with the theory of “removing stasis and promoting new”in Traditional Chinese Medicine.Based on this,treatment based on “Tonifying kidney and promoting blood circulation” in AA also benefit in improving the clinical efficiency.
作者 吴迪炯 洪耀南 孙泽星 周郁鸿 WU Dijiong;HONG Yaonan;SUN Zexing;ZHOU Yuhong(The First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou,310006;Zhejiang Provincial Hospital of Traditional Chinese Medicine,Hangzhou,310006;The First School of Clinical Medicine Zhejiang Chinese Medical University,Hangzhou,310053)
出处 《浙江中医杂志》 2024年第2期100-102,共3页 Zhejiang Journal of Traditional Chinese Medicine
基金 国家自然科学基金项目“补肾活血方”通过调控自噬介导的p53乙酰化减轻再生障碍性贫血造血干细胞“铁死亡”的机制研究,编号:82174138 浙江省卫生健康科技计划项目重型再生障碍性贫血患者脂质代谢的变化特征及其在联合免疫抑制治疗疗效评估中的价值研究,编号:2022RC216 浙江省中医药科技计划项目NRF2-HO-1通路在“补肾活血方”调控再生障碍性贫血骨髓脂肪细胞再生分化“铁损伤”中的作用研究,编号:2020ZB085。
关键词 再生障碍性贫血 瘀证 铁过载 活血 aplastic anemia stasis syndrome iron overload activating blood
  • 相关文献

参考文献9

二级参考文献56

  • 1秦旺华,印大中.中西医结合研究血瘀证本质的现状及进展[J].现代中西医结合杂志,2004,13(20):2659-2661. 被引量:6
  • 2吴晓勇.试论过敏性紫癜的中医病因病机与治疗[J].四川中医,2005,23(2):25-26. 被引量:14
  • 3周韶虹,甘晓芳,许毅.黄振翘从“泻肝清火,寓泻于补”论治再生障碍性贫血[J].上海中医药杂志,2007,41(6):10-11. 被引量:13
  • 4刘桂荣 马瑞梅.复方丹参治疗小儿过敏性紫癜的临床观察[J].中华儿科杂志,1998,9:521-521.
  • 5邓文龙.中药方剂的药理与应用[M].重庆:重庆出版社,1990.12-16.
  • 6Lee JW. Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea. Int J Hematol, 2008, 88: 16-23.
  • 7Fenaux P, Rose C. Impact of iron overload in myelodysplastic syndromes. Blood Rev, 2009, 23(Suppl 1 ): S15-S19.
  • 8Takatoku M, Uchiyama T, Okamoto S, et al. Retrospective nationwide survey of Japanese patients with transfusion- dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality. Eur J Haematol, 2007, 78: 487-494.
  • 9Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood, 2007, 109: 4586-4588.
  • 10Alessandrino EP, Angelucci E, Cazzola M, et al. Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo. Am J Hematol, 2011, 86: 897-902.

共引文献70

同被引文献36

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部